Seroprevalence of Hepatitis B Virus Infection and Associated Factors Among Blood Donors at a District Hospital in Ghana: A 2-Year Retrospective Study
- 1Methodist Hospital Wenchi, Ghana
Abstract
Background and AimsHepatitis B virus (HBV) infection remains a significant global public health concern, particularly in developing countries, where it poses a major challenge to safe blood transfusion services. Blood donors represent an important subset of the population for assessing HBV prevalence, as transfusions are a key route for transmission. This study aimed to determine the seroprevalence of HBV infection among blood donors at Methodist Hospital, Wenchi, Ghana.
MethodsA retrospective analysis was conducted using data from the blood bank at Methodist Hospital, Wenchi from January 2022 to December 2023 and analyzed using SPSS version 25.
ResultsThe overall HBV seroprevalence among blood donors was 6.8%, with a higher infection rate among females (16.7%) compared to males (6.3%). The highest seroprevalence (9.4%) occurred in donors aged 30-39 years and voluntary donors showed a higher infection rate (8.2%) than non-voluntary donors (6.5%). Among blood groups, individuals with blood groups A and B exhibited the highest infection rates (8.5%). Factors such as age (AOR: 2.62, 95% CI: 1.10 - 5.32, p-value =0.023), gender (AOR: 2.10, 95% CI: 1.05 - 4.35, p-value= 0.004) and Rhesus status (AOR: 1.68, 95% CI: 1.08 - 3.35, p-value= 0.031) were significantly associated with HBV infection.
ConclusionThe study revealed a significant HBV seroprevalence of 6.8% among blood donors, classifying the region as medium-endemic per WHO guidelines. The findings underscore the urgent need for enhanced HBV screening, rigorous blood safety measures and targeted public health interventions including vaccination and education campaigns to mitigate the transmission risk.
Related
- Seroprevalence and awareness of hepatitis C infection among informal workers at Kejetia Market, Ghana: A cross-sectional study
- The hidden burden of viral hepatitis B and C in healthcare settings: a cross-sectional study of seroprevalence, predictors, and occult infection
- Epidemiology, risk factors and outcomes of Clostridioides difficile infection in a UK district general hospital: a retrospective cohort study
- Documented Surgical Site Infection After Cesarean Delivery at Kiziguro District Hospital, Rwanda: A Retrospective Record Review.
- Identification of hepatitis B virus-associated membrane proteins as prognostic biomarkers for hepatocellular carcinoma based on retrospective analysis of integrated membrane proteomics
BibTeX
@misc{adjei2026seroprevalence,
title = {{Seroprevalence of Hepatitis B Virus Infection and Associated Factors Among Blood Donors at a District Hospital in Ghana: A 2-Year Retrospective Study}},
author = {S. K. Adjei and P. Adjei and E. Obeng},
howpublished = {medRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.10.26362725},
url = {https://www.medrxiv.org/content/10.64898/2026.09.10.26362725v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Seroprevalence of Hepatitis B Virus Infection and Associated Factors Among Blood Donors at a District Hospital in Ghana: A 2-Year Retrospective Study
AU - S. K. Adjei
AU - P. Adjei
AU - E. Obeng
PY - 2026
DA - 2026/09/10
PB - medRxiv
DO - 10.64898/2026.09.10.26362725
UR - https://www.medrxiv.org/content/10.64898/2026.09.10.26362725v1
AB - Background and AimsHepatitis B virus (HBV) infection remains a significant global public health concern, particularly in developing countries, where it poses a major challenge to safe blood transfusion services. Blood donors represent an important subset of the population for assessing HBV prevalence, as transfusions are a key route for transmission. This study aimed to determine the seroprevalence of HBV infection among blood donors at Methodist Hospital, Wenchi, Ghana. MethodsA retrospective analysis was conducted using data from the blood bank at Methodist Hospital, Wenchi from January 2022 to December 2023 and analyzed using SPSS version 25. ResultsThe overall HBV seroprevalence among blood donors was 6.8%, with a higher infection rate among females (16.7%) compared to males (6.3%). The highest seroprevalence (9.4%) occurred in donors aged 30-39 years and voluntary donors showed a higher infection rate (8.2%) than non-voluntary donors (6.5%). Among blood groups, individuals with blood groups A and B exhibited the highest infection rates (8.5%). Factors such as age (AOR: 2.62, 95% CI: 1.10 - 5.32, p-value =0.023), gender (AOR: 2.10, 95% CI: 1.05 - 4.35, p-value= 0.004) and Rhesus status (AOR: 1.68, 95% CI: 1.08 - 3.35, p-value= 0.031) were significantly associated with HBV infection. ConclusionThe study revealed a significant HBV seroprevalence of 6.8% among blood donors, classifying the region as medium-endemic per WHO guidelines. The findings underscore the urgent need for enhanced HBV screening, rigorous blood safety measures and targeted public health interventions including vaccination and education campaigns to mitigate the transmission risk.
ER -